SANDRA KURPELA: Open Payments
NPI 1215198569 · GRIFFITH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 11 payments from 8 companies in 2025. Trend: 2023 $1,854 · 2024 $758 · 2025 $626
Food & beverage: $606Education: $20
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| BridgeBio Pharma, Inc. | 1 | $124 |
| Madrigal Pharmaceuticals | 1 | $121 |
| PFIZER INC. | 2 | $104 |
| Merck Sharp & Dohme LLC | 1 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $11 |
Products named: AMVUTTRA, Attruby, REZDIFFRA, VYNDAQEL, WINREVAIR, Kerendia, LEQVIO, LifeVest.
Industry payments across IN — which companies pay providers there.
